Table 2.
Predocumented psychiatric diagnosis (PDPD) and psychiatric medication in PDPD patients
| PDPD | Patients, n (%) |
| F0 | 69 (34.7) |
| F1 | 71 (35.7) |
| F2 | 8 (4.0) |
| F3 | 68 (34.2) |
| F4 | 17 (8.5) |
| History of delirium | 14 (7.0) |
| Medication | |
| Antidepressant | 58 (29.1) |
| SSRI | 45 (22.6) |
| Tricyclic | 19 (9.6) |
| Benzodiazepine | 11 (5.5) |
| Antipsychotic | 33 (16.6) |
| First generation, high potency | 3 (1.5) |
| First generation, low potency | 19 (9.6) |
| Second generation | 14 (7.0) |
| Antidementive | 11 (5.5) |
Notes: F0, dementia (delirium was excluded); F1, substance-associated disorders (excluding tobacco, which was recorded separately); F2, schizophrenia and related disorders; F3, affective disorders; F4, anxiety, somatic–neurotic–stress disorders